Name: AUPH Insider Trading Activity
Creator: Tracefour
License: https://www.usa.gov/government-works
Keywords: AUPH, insider trading, SEC Form 4, insider transactions

Question 1

How many SEC Form 4 insider filings does AUPH have?

Accepted Answer

Aurinia Pharmaceuticals Inc. (AUPH) has 5 SEC Form 4 filings (9 transaction rows) in the rolling 365-day window, disclosed by 1 distinct insider. Most recent filing: Jun 3, 2026.

Question 2

When was the most recent SEC Form 4 filing for AUPH?

Accepted Answer

The most recent Form 4 filing for AUPH on Tracefour is dated Jun 3, 2026.

Question 3

Who is the most active insider at AUPH?

Accepted Answer

The most active SEC Form 4 filer at AUPH in the rolling window is Chief Executive Officer TANG KEVIN, with 3 filings.

Question 4

What is the net insider flow at AUPH over the last 6 months?

Accepted Answer

Over the trailing 180 days, insiders at AUPH have net bought $12.5M based on SEC Form 4 disclosures.

Question 5

What was the largest insider purchase at AUPH?

Accepted Answer

The largest single insider open-market purchase at AUPH in the rolling window was $5.3M by Chief Executive Officer TANG KEVIN on 2026-06-01.

Question 6

What is the total insider buy and sell value at AUPH in the current window?

Accepted Answer

Inside the rolling window, insiders at AUPH bought $12.5M and sold $0 based on SEC Form 4 filings.

						Source
TANG KEVINFirst filing	Chief Executive Officer	Purchase	264,981	$4.1M	Jun 3	SEC ↗
TANG KEVINFirst filing	Chief Executive Officer	Purchase	343,620	$5.3M	Jun 3	SEC ↗
TANG KEVINFirst filing	Chief Executive Officer	Purchase	206,005	$3.1M	Jun 3	SEC ↗

AUPH

Related companies